Literature DB >> 10383427

A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation.

M F Linton1, V R Babaev, L A Gleaves, S Fazio.   

Abstract

To evaluate the contribution of the macrophage low density lipoprotein receptor (LDLR) to atherosclerotic lesion formation, we performed bone marrow transplantation studies in different mouse strains. First, LDLR(-/-) mice were transplanted with either LDLR(+/+) marrow or LDLR(-/-) marrow and were challenged with an atherogenic Western type diet. The diet caused severe hypercholesterolemia of a similar degree in the two groups, and no differences in the aortic lesion area were detected. Thus, macrophage LDLR expression does not influence foam cell lesion formation in the setting of extreme LDL accumulation. To determine whether macrophage LDLR expression affects foam cell formation under conditions of moderate, non-LDL hyperlipidemia, we transplanted C57BL/6 mice with either LDLR(-/-) marrow (experimental group) or LDLR(+/+) marrow (controls). Cholesterol levels were not significantly different between the two groups at baseline or after 6 weeks on a butterfat diet, but were 40% higher in the experimental mice after 13 weeks, mostly due to accumulation of beta-very low density lipoprotein (beta-VLDL). Despite the increase in cholesterol levels, mice receiving LDLR(-/-) marrow developed 63% smaller lesions than controls, demonstrating that macrophage LDLR affects the rate of foam cell formation when the atherogenic stimulus is beta-VLDL. We conclude that the macrophage LDLR is responsible for a significant portion of lipid accumulation in foam cells under conditions of dietary stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383427     DOI: 10.1074/jbc.274.27.19204

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Signaling through LRP1: Protection from atherosclerosis and beyond.

Authors:  Philippe Boucher; Joachim Herz
Journal:  Biochem Pharmacol       Date:  2010-10-30       Impact factor: 5.858

2.  Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus.

Authors:  Aleksandar K Stanic; Charles M Stein; Adam C Morgan; Sergio Fazio; MacRae F Linton; Edward K Wakeland; Nancy J Olsen; Amy S Major
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

3.  The effect of 17β-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu.

Authors:  Michael P Corcoran; Alice H Lichtenstein; Mohsen Meydani; Alice Dillard; Ernst J Schaefer; Stefania Lamon-Fava
Journal:  J Mol Endocrinol       Date:  2011-08       Impact factor: 5.098

Review 4.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 5.  Animal models of atherosclerosis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

Review 6.  Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.

Authors:  Giuseppe Danilo Norata; Hagai Tavori; Angela Pirillo; Sergio Fazio; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2016-08-05       Impact factor: 10.787

7.  Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.

Authors:  Hagai Tavori; Ilaria Giunzioni; Irene M Predazzi; Deanna Plubell; Anna Shivinsky; Joshua Miles; Rachel M Devay; Hong Liang; Shirya Rashid; MacRae F Linton; Sergio Fazio
Journal:  Cardiovasc Res       Date:  2016-03-15       Impact factor: 10.787

8.  Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor.

Authors:  Debapriya Basu; Yunying Hu; Lesley-Ann Huggins; Adam E Mullick; Mark J Graham; Tomasz Wietecha; Shelley Barnhart; Allison Mogul; Katharina Pfeiffer; Andreas Zirlik; Edward A Fisher; Karin E Bornfeldt; Florian Willecke; Ira J Goldberg
Journal:  Circ Res       Date:  2018-01-10       Impact factor: 17.367

9.  Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages.

Authors:  J Allen Crow; Brandy L Middleton; Abdolsamad Borazjani; M Jason Hatfield; Philip M Potter; Matthew K Ross
Journal:  Biochim Biophys Acta       Date:  2008-08-05

10.  Local effects of human PCSK9 on the atherosclerotic lesion.

Authors:  Ilaria Giunzioni; Hagai Tavori; Roman Covarrubias; Amy S Major; Lei Ding; Youmin Zhang; Rachel M DeVay; Liang Hong; Daping Fan; Irene M Predazzi; Shirya Rashid; MacRae F Linton; Sergio Fazio
Journal:  J Pathol       Date:  2015-11-13       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.